![]() | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Asthma and Lung UK | |
![]() | |
Formation | January 1, 2020 |
---|---|
Merger of | Asthma UK British Lung Foundation |
Type | Charitable organisation |
Registration no. |
|
Purpose | Health policy |
Headquarters | The White Chapel Building, 10 Whitechapel High Street, London, E1 8QS |
Coordinates | 51°30′52″N0°04′22″W / 51.5145°N 0.0728°W |
Patron | The Duchess of Gloucester |
Key people | Sarah Sleet (CEO) Tamara Ingram (Chair) Professor Ian Hall (Vice Chair) |
Revenue | £15 million [1] (2022/23) |
Employees | 300 [1] (2023) |
Volunteers | 179 [1] (2023) |
Website | https://www.asthmaandlung.org.uk/ |
Formerly called | Asthma UK and British Lung Foundation Partnership |
Asthma + Lung UK (formally Asthma and Lung UK) is a British charity based in London, England. It focuses on respiratory health, in particular asthma and lung disease. [2] [3]
The organisation was formed in January 2020 as Asthma UK and the British Lung Foundation Partnership as a result of a merger between Asthma UK and the British Lung Foundation. [4] [5] On 24 February 2022, the charity announced that the organisation had been renamed to Asthma and Lung UK. [6]
The Asthma Research Council was founded in 1927. [7] The first donation was used to pay for special asthma clinics at Guy's Hospital and Great Ormond Street Hospital. In 1989, the Council became the National Asthma Campaign, and in 2004, it changed its name to Asthma UK.
The British Lung Foundation was established by Professor Sir Malcolm Green and a group of British lung specialists in 1984. [8]
In December 2019, Asthma UK and the British Lung Foundation announced that they had agreed to merge, to form Asthma UK and the British Lung Foundation Partnership. It was expected that the merged charity would save around £2 million a year in running costs compared to operating independently. Kay Boycott was appointed as the first chief executive of the partnership, having been the incumbent chief executive of Asthma UK at the time of the merger. [4] The British Lung Foundation's records with the Charity Commission and Companies House were renamed and remain in use, while Asthma UK's records were left dormant. [3] [9] [10] [11] On 24 February 2022, the charity announced that the organisation had been renamed to Asthma and Lung UK, styled as Asthma + Lung UK. [6]
Asthma + Lung UK appointed Sarah Sleet as its new chief executive officer in January 2024. [12] She replaced Sarah Woolnough, who had been in post for the previous three years. [13]
Asthma + Lung UK – and its previous incarnations – is known for the research it has been carrying out into asthma and lung disease for the past decades. It has informed a number of parliamentary debates on the issue. [14] [15] [16]
Since 2012, Asthma UK has conducted an annual survey of people with asthma, [17] looking into their experience of living with the condition and the care they receive. [18] [19] [20] The survey has been taken over and continued by Asthma + Lung UK since the merger with the British Lung Foundation. [21]
In 2014, Asthma UK founded the Centre for Applied Research in asthma at the University of Edinburgh. [22] The Centre has been a regular participant in the Scottish Parliament's Cross-Party Group on Lung Health since its inception in 2021. [23] [24]
In 2018 the British Lung Foundation helped found the Taskforce for Lung Health, [25] which brought together representatives from over 40 organisations in the sector to make recommendations on how to improve treatment for lung disease in the UK. In 2020, the taskforce revealed that lung patients’ symptoms had improved during lockdown as a result of a drop in air pollution. [26] However in 2021, it warned that one fifth of lung disease patients had to wait more than a year for a prognosis, and risked dying before they were even diagnosed. [27]
In 2023, Asthma + Lung UK published research which suggested up to 750,000 people in England were being misdiagnosed with asthma, due to a lack of simple tests for common lung conditions. [28] [29] The research claimed these misdiagnoses cost the government an estimated £132 million each year.
Research published by the charity in 2024 showed that while deaths from asthma attacks were up by a quarter since 2010, two thirds of asthma deaths were preventable. [30]
In 2021-22, Asthma + Lung UK raised £13.9 million. [31] Of this amount, £5.1m came from legacies (37%), £4.3m from donations (31%), £1.4m from fundraising (10%), £1.3m from grants (9%), £0.5m from gifts in kind (4%), and £0.4m from its investment portfolio (3%).
Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.
Animal Free Research UK (AFRUK), formerly the Dr Hadwen Trust, is a UK medical research charity that funds and promotes non-animal techniques to replace animal experiments. Established in 1970, the work undertaken by Animal Free Research UK develops reliable science whilst avoiding animal testing.
Sir Magdi Habib Yacoub is an Egyptian-British retired professor of cardiothoracic surgery at Imperial College London, best known for his early work in repairing heart valves with surgeon Donald Ross, adapting the Ross procedure, where the diseased aortic valve is replaced with the person's own pulmonary valve, devising the arterial switch operation (ASO) in transposition of the great arteries, and establishing the heart transplantation centre at Harefield Hospital in 1980 with a heart transplant for Derrick Morris, who at the time of his death was Europe's longest-surviving heart transplant recipient. Yacoub subsequently performed the UK's first combined heart and lung transplant in 1983.
The British Heart Foundation (BHF) is a cardiovascular research charity in the United Kingdom. It funds medical research related to heart and circulatory diseases and their risk factors, and runs influencing work aimed at shaping public policy and raising awareness.
Action on Smoking and Health (ASH) is the name of a number of autonomous pressure groups (charities) in the anglosphere that seek to publicize the risks associated with tobacco smoking and campaign for greater restrictions on use and on cigarette and tobacco sales.
Royal Brompton Hospital is the largest specialist heart and lung medical centre in the United Kingdom. It is managed by Guy's and St Thomas' NHS Foundation Trust.
The Royal Marsden Hospital is a specialist National Health Service oncology hospital in London based at two sites in Brompton, in Kensington and Chelsea, and Belmont in Sutton. It is managed by The Royal Marsden NHS Foundation Trust and supported by The Royal Marsden Cancer Charity.
NHS Scotland, sometimes styled NHSScotland, is the publicly–funded healthcare system in Scotland and one of the four systems that make up the National Health Service in the United Kingdom. It operates 14 territorial NHS boards across Scotland, supported by seven special non-geographic health boards, and Public Health Scotland.
Rethink Mental Illness Is a British charity that seeks to improve the lives of severely mentally ill people.
The health of the Scottish population is, and has been for many years, worse than that of the English. Life expectancy is the lowest in the UK, at 77.1 for men and 81.1 for women, and one of the lowest in the OECD. The gap between Scotland and England has grown since 1980. Some of this is clearly attributable to economic disadvantage, but the differences in health status are more pronounced that would be expected on that basis. It has often been suggested that the Scottish diet is to blame. This is particularly so in Glasgow and the Glasgow effect has been the subject of some academic study.
The National Health Service (NHS) is the publicly funded healthcare system in England, and one of the four National Health Service systems in the United Kingdom. It is the second largest single-payer healthcare system in the world after the Brazilian Sistema Único de Saúde. Primarily funded by the government from general taxation, and overseen by the Department of Health and Social Care, the NHS provides healthcare to all legal English residents and residents from other regions of the UK, with most services free at the point of use for most people. The NHS also conducts research through the National Institute for Health and Care Research (NIHR).
The National Health Service (NHS) is the umbrella term for the publicly funded healthcare systems of the United Kingdom, comprising the NHS in England, NHS Scotland and NHS Wales. Health and Social Care in Northern Ireland was created separately and is often locally referred to as "the NHS". The original three systems were established in 1948 as part of major social reforms following the Second World War. The founding principles were that services should be comprehensive, universal and free at the point of delivery. Each service provides a comprehensive range of health services, provided without charge for residents of the United Kingdom apart from dental treatment and optical care. In England, NHS patients have to pay prescription charges; some, such as those aged over 60, or those on certain state benefits, are exempt.
Air pollution in the United Kingdom has long been considered a significant health issue, and it causes numerous other environmental problems such as damage to buildings, forests, and crops. Many areas, including major cities like London, are found to be significantly and regularly above legal and recommended pollution levels. Air pollution in the UK is a major cause of diseases such as asthma, lung disease, stroke, cancer, and heart disease, and it costs the health service, society, and businesses over £20 billion each year. Outdoor pollution alone is estimated to cause 40,000 early deaths each year, which is about 8.3% of deaths.
The Canadian Lung Association is a national organization and volunteer-based health charity that supports lung health research, education, prevention of disease/disorders and advocacy in Canada.
The Royal Foundation of The Prince and Princess of Wales is an independent United Kingdom-based charity which supports the non-profit work of the Prince and Princess of Wales. Their projects revolve around conservation, environmental issues, early childhood development, mental health, emergency services, and homelessness.
Suicide is a significant national social issue in the United Kingdom. In 2022 there were 5,642 registered deaths by suicide in England and Wales, equating to an average of 15 suicides per day. 74.1% of suicides in England and Wales in 2022 were males. In Scotland there were 762 probable suicides in 2022, equating to an average of 2 suicides per day. In Northern Ireland there were 203 suicide deaths registered in 2022. Suicide is the biggest killer of men under the age of 50 in the UK.
Versus Arthritis is the United Kingdom's largest charity dedicated to supporting people with arthritis. It was launched in 2018, following the legal merger of the country's two leading arthritis charities, Arthritis Research UK and Arthritis Care in 2017.
The COVID-19 pandemic in Scotland is part of the COVID-19 pandemic of coronavirus disease-2019, caused by the virus SARS-CoV-2. The first case of COVID-19 was confirmed in Scotland on 1 March 2020. Community transmission was first reported on 11 March 2020, and the first confirmed death was on 13 March 2020.
John W. Walsh was an American non-profit leader and patient advocate. After being diagnosed with alpha-1 antitrypsin deficiency, he co-founded the Alpha-1 Foundation and AlphaNet, both of which serve people diagnosed with that condition, and the COPD Foundation, which serves people with chronic obstructive pulmonary disease. As an advocate for alpha-1 and COPD patients, Walsh lobbied before Congress for increased research funding and medical benefits for patients, and served on a number of health-related committees and organizations.
The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom.